Adverse Outcomes and Mortality in Liver Transplant
Recruiting · NCT05477277 · Interventional (participants receive a specific treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →Interventions studied
MAsS
What this trial is about
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- All patients with end-stage liver disease undergoing evaluation for liver transplantation
- Patient clinically indicated for MRI during transplant candidacy evaluation
- Adult
Exclusion criteria
- \. Contra indication to MRI
Where it is running
1 location listed across 1 US state.
- Mayo Clinic Arizona - Phoenix, Arizona, United States